{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:03:37Z","timestamp":1791068617206,"version":"4.1.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005681","name":"Genesis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100013226","name":"Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004342","name":"Wyeth","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005622","name":"Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"},{"name":"BMS"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"name":"GSK"},{"DOI":"10.13039\/501100006201","name":"ISA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006201","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejca.2020.01.007","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T08:32:18Z","timestamp":1582705938000},"page":"60-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"special_numbering":"C","title":["European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention"],"prefix":"10.1016","volume":"128","author":[{"given":"Alexander J.","family":"Stratigos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio","family":"Dessinioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Lebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bastholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Forsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecille","family":"Frenard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine \u0391.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Kandolf-Sekulovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole WJ.","family":"Kelleners-Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"del Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moreno-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pellecani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Saiag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke H.J.","family":"van den Beuken-van Everdingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.M.","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.01.007_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","article-title":"Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline","volume":"51","author":"Stratigos","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.01.007_bib2","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. squamous cell skin cancer. version 2.2019-October 23, 2018 ed. Available at NCCN.org."},{"key":"10.1016\/j.ejca.2020.01.007_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaad.2017.10.007","article-title":"Guidelines of care for the management of cutaneous squamous cell carcinoma","volume":"78","author":"Work","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib4","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1017\/S0022215116000554","article-title":"Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Newlands","year":"2016","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.ejca.2020.01.007_bib5","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.ejca.2020.01.007_bib6","unstructured":"Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. In: Group OLoEW, editor. the oxford levels of evidence 2: Oxford Center for Evifdence-Based Medicine. https:\/\/www.cebm.net\/index.aspx?o=5653. Access Date: 23 April 2019."},{"key":"10.1016\/j.ejca.2020.01.007_bib7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","article-title":"Keratinocyte carcinomas: current concepts and future research priorities","volume":"25","author":"Nagarajan","year":"2019","journal-title":"Clin Canc Res: An Off J Am Assoc Canc Res"},{"key":"10.1016\/j.ejca.2020.01.007_bib8","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/bjd.16536","article-title":"Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses","volume":"180","author":"Schmitz","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jdv.12848","article-title":"Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin","volume":"29","author":"Fernandez-Figueras","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2020.01.007_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib13","series-title":"TNM Classification of malignant umours","year":"2017"},{"key":"10.1016\/j.ejca.2020.01.007_bib14","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.ejca.2020.01.007_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: an epidemiological review","volume":"177","author":"Green","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib20","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/bjd.15110","article-title":"Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology","volume":"176","author":"Goon","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/jama.1989.03430150065027","article-title":"The emerging epidemic of melanoma and squamous cell skin cancer","volume":"262","author":"Glass","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2020.01.007_bib22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archderm.1997.03890420073008","article-title":"Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992","volume":"133","author":"Gray","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5694\/mja17.00284","article-title":"The incidence and multiplicity rates of keratinocyte cancers in Australia","volume":"207","author":"Pandeya","year":"2017","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejca.2020.01.007_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjd.12988","article-title":"Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention","volume":"171","author":"Deady","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamadermatol.2018.4219","article-title":"Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England","volume":"155","author":"Venables","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study","volume":"181","author":"Venables","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cam4.404","article-title":"Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality","volume":"4","author":"Robsahm","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/1346-8138.14759","article-title":"Incidence rate of cutaneous squamous cell carcinoma is rapidly increasing in Akita Prefecture: Urgent alert for super-aged society","volume":"46","author":"Umezono","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib30","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2017.02.015","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in olmsted county, minnesota, 2000 to 2010","volume":"92","author":"Muzic","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejca.2020.01.007_bib31","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1111\/jdv.14052","article-title":"Non-melanoma skin cancer mortality rising in susceptible Australians","volume":"31","author":"Czarnecki","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2020.01.007_bib32","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.canep.2011.05.006","article-title":"Incidence of cutaneous squamous cell carcinoma in coastal and inland areas of Western Sweden","volume":"35","author":"Andersson","year":"2011","journal-title":"Canc Epidemiol"},{"key":"10.1016\/j.ejca.2020.01.007_bib33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jamadermatol.2013.5273","article-title":"Press for an underestimated nemesis","volume":"149","author":"Carucci","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jso.23155","article-title":"The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors","volume":"106","author":"Brougham","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jso.24707","article-title":"Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: Do we need to adjust our thinking on this rare but potentially fatal event?","volume":"116","author":"Nelson","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib38","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hed.25114","article-title":"Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy","volume":"40","author":"Xu","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2020.01.007_bib39","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cncr.30601","article-title":"A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck","volume":"123","author":"Manyam","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.01.007_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hed.23283","article-title":"Cancer of the head and neck region in solid organ transplant recipients","volume":"36","author":"Rabinovics","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2020.01.007_bib41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hed.25069","article-title":"Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion","volume":"40","author":"Lam","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2020.01.007_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2016.02.1155","article-title":"Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013","volume":"75","author":"Garrett","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib43","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaad.2005.08.055","article-title":"Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia","volume":"53","author":"Mehrany","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamadermatol.2013.6249","article-title":"Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia","volume":"150","author":"Velez","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaad.2014.10.028","article-title":"Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota","volume":"72","author":"Brewer","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib46","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jid.2017.06.025","article-title":"Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study","volume":"137","author":"Eigentler","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib47","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jamadermatol.2018.1118","article-title":"Prevalence of skin cancer examination among users of indoor tanning beds","volume":"154","author":"Morris","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib48","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamadermatol.2015.4530","article-title":"Association between beta-Genus human papillomavirus and cutaneous squamous cell carcinoma in immunocompetent individuals-A meta-analysis","volume":"152","author":"Chahoud","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib49","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/bjd.18212","article-title":"The detection rate of human papillomavirus in well-differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?","volume":"181","author":"Conforti","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41416-018-0105-y","article-title":"Heterogeneous relationships of squamous and basal cell carcinomas of the skin with smoking: the UK Million Women Study and meta-analysis of prospective studies","volume":"119","author":"Pirie","year":"2018","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejca.2020.01.007_bib51","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jid.2017.03.027","article-title":"Cigarette smoking and the risks of basal cell carcinoma and squamous cell carcinoma","volume":"137","author":"Dusingize","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib52","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ccell.2016.04.004","article-title":"Squamous cell cancers: a unified perspective on biology and genetics","volume":"29","author":"Dotto","year":"2016","journal-title":"Canc cell"},{"key":"10.1016\/j.ejca.2020.01.007_bib53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejca.2020.01.007_bib54","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib55","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bjd.15932","article-title":"Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma","volume":"177","author":"Harwood","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib56","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2018.03.024","article-title":"Risk of skin cancer in patients with HIV: A Danish nationwide cohort study","volume":"79","author":"Omland","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib58","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jid.2018.08.025","article-title":"Reduced-intensity conditioning regimens, prior chronic lymphocytic leukemia, and graft-versus-host disease are associated with higher rates of skin cancer after allogeneic hematopoietic stem cell transplantation","volume":"139","author":"Wu","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamadermatol.2015.3902","article-title":"Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study","volume":"152","author":"Omland","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib60","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/jamadermatol.2017.1716","article-title":"Association of multiple primary skin cancers with human immunodeficiency virus infection, CD4 Count, and viral load","volume":"153","author":"Asgari","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib61","doi-asserted-by":"crossref","first-page":"83280","DOI":"10.18632\/oncotarget.21059","article-title":"Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF\/MEK inhibitors in cancer patients: a meta-analysis","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2020.01.007_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","article-title":"Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF","volume":"140","author":"Heidorn","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2020.01.007_bib63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2020.01.007_bib64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib65","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jamadermatol.2015.4330","article-title":"Increased risk of cutaneous squamous cell carcinoma after vismodegib therapy for basal cell carcinoma","volume":"152","author":"Mohan","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib66","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jamadermatol.2016.0780","article-title":"Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies","volume":"152","author":"Jacobsen","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib67","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/bjd.16713","article-title":"Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma","volume":"179","author":"Su","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib68","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.12.003","article-title":"Anti-hypertensive drugs and skin cancer risk: A review of the literature and meta-analysis","volume":"122","author":"Gandini","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2020.01.007_bib70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pds.4384","article-title":"Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies","volume":"27","author":"Tang","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ejca.2020.01.007_bib71","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/jid.2014.154","article-title":"NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib72","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2020.01.007_bib73","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1038\/ncomms12601","article-title":"Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates","volume":"7","author":"Chitsazzadeh","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2020.01.007_bib74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2020.01.007_bib75","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/ncomms12493","article-title":"Inactivation of TGFbeta receptors in stem cells drives cutaneous squamous cell carcinoma","volume":"7","author":"Cammareri","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2020.01.007_bib76","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies","volume":"122","author":"Al-Rohil","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.01.007_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aas9668","article-title":"APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa","volume":"10","author":"Cho","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib78","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1038\/ncomms12048","article-title":"Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma","volume":"7","author":"Chahal","year":"2016","journal-title":"Nat commun"},{"key":"10.1016\/j.ejca.2020.01.007_bib79","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jid.2017.09.034","article-title":"Susceptibility loci-associated cutaneous squamous cell carcinoma invasiveness","volume":"138","author":"Wang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib80","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1038\/s41467-018-06149-6","article-title":"Gene expression imputation identifies candidate genes and susceptibility loci associated with cutaneous squamous cell carcinoma","volume":"9","author":"Ioannidis","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2020.01.007_bib81","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jid.2018.01.031","article-title":"Quantifying the polygenic contribution to cutaneous squamous cell carcinoma risk","volume":"138","author":"Sordillo","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib82","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.humimm.2017.02.002","article-title":"Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system","volume":"78","author":"Yesantharao","year":"2017","journal-title":"Human Immunol"},{"key":"10.1016\/j.ejca.2020.01.007_bib83","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00262-018-2138-8","article-title":"PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma","volume":"67","author":"Varki","year":"2018","journal-title":"Canc Immunol Immunother"},{"key":"10.1016\/j.ejca.2020.01.007_bib84","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bjd.14955","article-title":"The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma","volume":"176","author":"Schaper","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib85","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/DAD.0000000000001164","article-title":"PD-L1 expression is increased in metastasizing squamous cell carcinomas and their metastases","volume":"40","author":"Garcia-Diez","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2020.01.007_bib86","series-title":"WHO classification of skin tumors","first-page":"35","article-title":"Squamous cell carcinoma","author":"Murphy","year":"2018"},{"key":"10.1016\/j.ejca.2020.01.007_bib87","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/DAD.0000000000000031","article-title":"Keratoacanthoma clinical behavior: a systematic review","volume":"36","author":"Savage","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2020.01.007_bib88","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archdermatol.2012.2974","article-title":"Dermoscopy of squamous cell carcinoma and keratoacanthoma","volume":"148","author":"Rosendahl","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib89","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/bjd.13510","article-title":"The clinical and dermoscopic features of invasive cutaneous squamous cell carcinoma depend on the histopathological grade of differentiation","volume":"172","author":"Lallas","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib90","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaad.2011.02.011","article-title":"Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model","volume":"66","author":"Zalaudek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib91","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archdermatol.2009.134","article-title":"Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses","volume":"145","author":"Rishpon","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib92","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/jdv.14463","article-title":"Dermoscopic and reflectance confocal microscopy features of cutaneous squamous cell carcinoma","volume":"31","author":"Manfredini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2020.01.007_bib93","first-page":"CD013191","article-title":"Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults","volume":"12","author":"Dinnes","year":"2018","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.ejca.2020.01.007_bib94","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/jdv.12954","article-title":"High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma","volume":"29","author":"Boone","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2020.01.007_bib95","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jdv.14335","article-title":"In vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography","volume":"31","author":"Themstrup","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2020.01.007_bib96","first-page":"CD013189","article-title":"Optical coherence tomography for diagnosing skin cancer in adults","volume":"12","author":"Ferrante di Ruffano","year":"2018","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.ejca.2020.01.007_bib97","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamadermatol.2017.4506","article-title":"Cutaneous squamous cell carcinomas in solid organ transplant recipients compared with immunocompetent patients","volume":"154","author":"Cheng","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib98","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ijd.12553","article-title":"Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends","volume":"54","author":"Kallini","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib99","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2559.2000.00999.x","article-title":"Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin","volume":"37","author":"Beer","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2020.01.007_bib100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<915::AID-CNCR7>3.0.CO;2-A","article-title":"Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer","volume":"79","author":"Breuninger","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.01.007_bib101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2013.746","article-title":"Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study","volume":"149","author":"Carter","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib102","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejca.2018.01.075","article-title":"Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG","volume":"96","author":"Hillen","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.01.007_bib103","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2559.2006.02472.x","article-title":"Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips","volume":"49","author":"Quaedvlieg","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2020.01.007_bib104","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaad.2018.09.015","article-title":"Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone","volume":"80","author":"Marrazzo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib105","first-page":"268","article-title":"Prognostic factors for metastasis in squamous cell carcinoma of the skin","volume":"28","author":"Cherpelis","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2020.01.007_bib106","first-page":"37","article-title":"Squamous cell carcinoma of the skin--histopathological features and their significance for the clinical outcome","volume":"11","author":"Petter","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2020.01.007_bib107","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamadermatol.2017.1680","article-title":"Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: A systematic review and pooled analysis of outcomes data","volume":"153","author":"Karia","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib108","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib109","first-page":"579","article-title":"Comparison and evaluation of the current staging of cutaneous carcinomas","volume":"10","author":"Breuninger","year":"2012","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatol : JDDG."},{"key":"10.1016\/j.ejca.2020.01.007_bib110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamadermatol.2017.3960","article-title":"Comparison of tumor classifications for cutaneous squamous cell carcinoma of the head and neck in the 7th vs 8th edition of the AJCC cancer staging manual","volume":"154","author":"Karia","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib111","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hed.25599","article-title":"A critical analysis of the prognostic performance of the 8th edition American Joint Committee on cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck","volume":"41","author":"Sood","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2020.01.007_bib112","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jso.24883","article-title":"Predictive value of the 8th edition American Joint Commission Cancer (AJCC) nodal staging system for patients with cutaneous squamous cell carcinoma of the head and neck","volume":"117","author":"Liu","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib113","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1245\/s10434-018-6340-x","article-title":"Analysis and comparison of the 8th edition American Joint Committee on Cancer (AJCC) nodal staging system in cutaneous and oral squamous cell cancer of the head and neck","volume":"25","author":"Moeckelmann","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib114","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, international union against cancer, and brigham and women's hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamadermatol.2017.6428","article-title":"Validating 4 staging systems for cutaneous squamous cell carcinoma using population-based data: A nested case-control study","volume":"154","author":"Roscher","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib116","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/jamadermatol.2018.3940","article-title":"Staging systems to predict metastatic cutaneous squamous cell carcinoma: unsatisfactory for clinical use, but some less so?","volume":"154","author":"Abraham","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib117","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American Joint Committee on cancer staging manual, 8th edition vs the brigham and women\u2019s hospital tumor classification system for cutaneous squamous cell carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib118","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaad.2018.08.018","article-title":"Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia","volume":"80","author":"Inda","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib119","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2018.09.006","article-title":"Nodal staging of high-risk cutaneous squamous cell carcinoma","volume":"81","author":"Fox","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bjoms.2014.01.015","article-title":"Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma","volume":"52","author":"Gurney","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.ejca.2020.01.007_bib121","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2016.08.051","article-title":"The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management","volume":"76","author":"Ruiz","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib122","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejrad.2007.02.037","article-title":"Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging","volume":"64","author":"de Bondt","year":"2007","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejca.2020.01.007_bib123","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/ijgc-00009577-200601000-00050","article-title":"Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva","volume":"16","author":"Land","year":"2006","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.ejca.2020.01.007_bib124","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2015.10.009","article-title":"The role of imaging in the management of patients with nonmelanoma skin cancer: When is imaging necessary?","volume":"76","author":"Humphreys","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0360-3016(00)01407-3","article-title":"Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis","volume":"49","author":"Williams","year":"2001","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"key":"10.1016\/j.ejca.2020.01.007_bib126","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2015.10.010","article-title":"The role of imaging in the management of patients with nonmelanoma skin cancer: Diagnostic modalities and applications","volume":"76","author":"MacFarlane","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib127","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/hed.23982","article-title":"Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma","volume":"38","author":"Warren","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2020.01.007_bib128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/hed.21470","article-title":"Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing \"targeted\" MRI with the histologic findings following surgery","volume":"33","author":"Gandhi","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2020.01.007_bib129","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hed.21986","article-title":"Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck","volume":"34","author":"Panizza","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2020.01.007_bib130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaad.2015.03.039","article-title":"High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: A literature review","volume":"73","author":"Navarrete-Dechent","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib131","first-page":"786","article-title":"Sentinel lymph node biopsy for high-risk nonmelanoma skin cancers","volume":"33","author":"Sahn","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2020.01.007_bib132","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/bjd.13508","article-title":"Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma","volume":"172","author":"Krediet","year":"2015","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2020.01.007_bib133","first-page":"E884","article-title":"Prospective study of sentinel node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck","volume":"38","author":"Gore","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2020.01.007_bib134","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/1346-8138.12508","article-title":"Evaluation of sentinel node biopsy for cutaneous squamous cell carcinoma","volume":"41","author":"Fukushima","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib135","first-page":"135","article-title":"Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma","volume":"29","author":"Reschly","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2020.01.007_bib136","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejso.2014.10.055","article-title":"Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma","volume":"41","author":"Allen","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib137","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib138","first-page":"1309","article-title":"Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature","volume":"32","author":"Ross","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2020.01.007_bib139","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejso.2006.10.017","article-title":"Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature","volume":"33","author":"Renzi","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib140","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/1346-8138.14342","article-title":"Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma","volume":"45","author":"Tejera-Vaquerizo","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib141","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2340\/00015555-2942","article-title":"Sentinel lymph node biopsy in cutaneous squamous cell carcinoma series of 37 cases and systematic review of the literature","volume":"98","author":"Lhote","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2020.01.007_bib142","first-page":"422","article-title":"Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: A systematic review","volume":"27","author":"Saraiya","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib143","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/0278-6133.25.1.34","article-title":"Evaluation of a multicomponent appearance-based sun-protective intervention for young women: uncovering the mechanisms of program efficacy","volume":"25","author":"Jackson","year":"2006","journal-title":"Health Psychol"},{"key":"10.1016\/j.ejca.2020.01.007_bib144","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CEJ.0000000000000056","article-title":"Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review","volume":"24","author":"Gordon","year":"2015","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ejca.2020.01.007_bib145","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.2017.21630","article-title":"Behavioral counseling for skin cancer prevention: evidence report and systematic review for the US preventive services task force","volume":"319","author":"Henrikson","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2020.01.007_bib146","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.amepre.2016.03.020","article-title":"Community-wide interventions to prevent skin cancer: Two community guide systematic reviews","volume":"51","author":"Sandhu","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib147","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1080\/10810730.2013.778361","article-title":"Randomized trial of tailored skin cancer prevention for children: the project SCAPE family study","volume":"18","author":"Glanz","year":"2013","journal-title":"J Health Commun"},{"key":"10.1016\/j.ejca.2020.01.007_bib148","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ypmed.2014.12.009","article-title":"Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial","volume":"71","author":"Youl","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib149","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","article-title":"Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial","volume":"354","author":"Green","year":"1999","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejca.2020.01.007_bib150","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1158\/1055-9965.EPI-06-0352","article-title":"Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use","volume":"15","author":"van der Pols","year":"2006","journal-title":"Canc Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2020.01.007_bib151","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1684\/ejd.2018.3251","article-title":"Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis","volume":"28","author":"Silva","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib152","first-page":"875","article-title":"New developments in occupational dermatology","volume":"14","author":"Diepgen","year":"2016","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatol: JDDG"},{"key":"10.1016\/j.ejca.2020.01.007_bib153","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/HP.0b013e3181d85908","article-title":"ICNIRP statement--Protection of workers against ultraviolet radiation","volume":"99","author":"International Commission on Non-Ionizing Radiation P","year":"2010","journal-title":"Health Phys"},{"key":"10.1016\/j.ejca.2020.01.007_bib154","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.seminoncol.2016.02.019","article-title":"Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment","volume":"43","author":"Kim","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am J Transpl: Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2020.01.007_bib156","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ypmed.2005.11.007","article-title":"A randomized intervention study of sun protection promotion in well-child care","volume":"42","author":"Crane","year":"2006","journal-title":"Prev Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib157","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5993\/AJHB.34.4.11","article-title":"The sun sense study: an intervention to improve sun protection in children","volume":"34","author":"Glasser","year":"2010","journal-title":"Am J Health Behav"},{"key":"10.1016\/j.ejca.2020.01.007_bib158","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archpedi.161.2.146","article-title":"A randomized trial of a multicomponent intervention for adolescent sun protection behaviors","volume":"161","author":"Norman","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib159","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/109019810102800304","article-title":"Slip! Slop! Slap! and SunSmart, 1980-2000: Skin cancer control and 20 years of population-based campaigning","volume":"28","author":"Montague","year":"2001","journal-title":"Health Educ Behav"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2020.01.007_bib160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2009.09443.x","article-title":"Certification of sun protection practices in a German child day-care centre improves children\u2019s sun protection--the \u2018SunPass\u2019 pilot study","volume":"161","author":"Aulbert","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib161","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/her\/16.5.623","article-title":"Evaluation of \u2018Sun-safe\u2019: a health education resource for primary schools","volume":"16","author":"Hewitt","year":"2001","journal-title":"Health Educ Res"},{"key":"10.1016\/j.ejca.2020.01.007_bib162","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/109019819902600307","article-title":"The Falmouth Safe Skin Project: evaluation of a community program to promote sun protection in youth","volume":"26","author":"Miller","year":"1999","journal-title":"Health Educ Behav"},{"key":"10.1016\/j.ejca.2020.01.007_bib163","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2019.02.004","article-title":"Topical and systemic modalities for chemoprevention of nonmelanoma skin cancer","volume":"37","author":"Nemer","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ejca.2020.01.007_bib164","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.26374","article-title":"Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)","volume":"118","author":"Kadakia","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.01.007_bib165","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1067\/S0190-9622(03)01587-1","article-title":"Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study","volume":"49","author":"Nijsten","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib166","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/bjd.12519","article-title":"Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors","volume":"169","author":"Anforth","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib167","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archderm.141.4.456","article-title":"Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study","volume":"141","author":"Harwood","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib168","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2005.06347.x","article-title":"Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials","volume":"152","author":"Chen","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib169","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.jid.5701058","article-title":"UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide","volume":"128","author":"Damian","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib170","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.01.007_bib171","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.14662","article-title":"A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib172","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjd.15203","article-title":"Reply to \u2018A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients\u2019","volume":"176","author":"Yelamos","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib173","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjd.15204","article-title":"Authors\u2019 response to a reply to \u2018A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients\u2019","volume":"176","author":"Damian","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib174","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/jid.2014.531","article-title":"Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"135","author":"Muranushi","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.29357","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer","volume":"137","author":"Reinau","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2020.01.007_bib176","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/bjd.17938","article-title":"Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia","volume":"181","author":"Pandeya","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib177","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2011.34.5967","article-title":"Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women\u2019s health initiative randomized controlled trial","volume":"29","author":"Tang","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib178","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","article-title":"Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: A randomized clinical trial","volume":"154","author":"Weinstock","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib179","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125476","article-title":"Skin cancer precursor immunotherapy for squamous cell carcinoma prevention","volume":"4","author":"Rosenberg","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejca.2020.01.007_bib180","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib181","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaad.2015.05.029","article-title":"Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)","volume":"73","author":"Asgari","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2020.01.007_bib182","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejca.2020.01.007_bib183","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2020.01.007_bib184","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.2017.76.6691","article-title":"Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results","volume":"36","author":"Dantal","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.01.007_bib185","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.15950","article-title":"Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"177","author":"Blomberg","year":"2017","journal-title":"Br J Dermatol"},{"issue":"Suppl 5","key":"10.1016\/j.ejca.2020.01.007_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04296.x","article-title":"Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions","volume":"25","author":"Bonerandi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920300186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920300186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:27:59Z","timestamp":1760732879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920300186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":184,"alternative-id":["S0959804920300186"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.01.007","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}